The IPO aims to tap into a rapidly growing health care market that is central to the kingdom’s diversification strategy. Saudi Arabia's expanding population and increasing life expectancy have made health care a key pillar in the nation's long-term development plans. This is reflected in the surge of public listings in the sector, with notable recent IPOs such as the Middle East Pharmaceutical Company and Dr. Soliman Fakeeh Hospital Co. Both of these ventures have performed strongly since their debut on the stock exchange, signaling a robust appetite for health care investments in the kingdom.
Almoosa is collaborating with several financial institutions, including EFG Hermes, Saudi Fransi Capital, and Moelis & Co., to manage the IPO. Two major investors, Tawuniya and Alfozan Holding, have already committed to subscribing to 22% of the offering. Following the IPO, these investors will collectively hold around 6.6% of Almoosa's shares.
This offering comes on the heels of a dynamic year for Saudi Arabia’s stock market, which has seen a record number of IPOs across various sectors. Health care listings have gained particular traction, as the country accelerates efforts to transform its health system and expand the private sector’s involvement in this space. Almoosa’s IPO is poised to add momentum to this trend, reinforcing the kingdom's positioning as a leading market for health care-related investments in the region.